Medication (generic)
Insulin glargine (U100)
Starting dose
10 units at bedtime or 0.1-0.2 units/kg
Typical titration / target
Increase by 2 units every 3 days to fasting target
Monitoring / notes
Review hypoglycemia risk and injection technique.
Prescribing
Basal insulin initiation
Practical starting doses and titration for basal insulin in type 2 diabetes.
Last reviewed 2026-01-05|endocrine | diabetes | insulin
Editorial feedback
Suggest an update
Flag outdated guidance or propose revised wording for this page. Do not include PHI or patient identifiers.
Jump to
Dosing quick reference
Medication (generic)
Insulin NPH
Starting dose
10 units at bedtime
Typical titration / target
Increase by 2 units every 3 days to fasting target
Monitoring / notes
Higher nocturnal hypoglycemia risk; consider SMBG overnight.
| Medication (generic) | Starting dose | Typical titration / target | Monitoring / notes |
|---|---|---|---|
| Insulin glargine (U100) | 10 units at bedtime or 0.1-0.2 units/kg | Increase by 2 units every 3 days to fasting target | Review hypoglycemia risk and injection technique. |
| Insulin NPH | 10 units at bedtime | Increase by 2 units every 3 days to fasting target | Higher nocturnal hypoglycemia risk; consider SMBG overnight. |
Contraindications
- Do not initiate basal insulin during active hypoglycemia.
- Defer routine outpatient starts when severe acute illness or ketosis concern is present.
- Verify insulin product and concentration carefully to avoid dosing errors.
Renal and hepatic considerations
- Start conservatively and titrate carefully when renal function is reduced.
- Use additional caution in significant hepatic impairment due to altered glucose handling.
- Reassess dosing pace when oral intake is inconsistent or frailty is present.
Pregnancy and lactation cautions
- Pregnancy requires individualized glycemic targets and medication planning.
- Review preconception goals and coordinate early obstetric/diabetes support when relevant.
- During lactation, reinforce hypoglycemia prevention and individualized dose reassessment.
Monitoring checkpoints
- Titrate slowly with fasting SMBG; pause titration if hypoglycemia occurs.
- Ensure patients understand sick day management and hypoglycemia treatment.
- Reassess A1C in 3 months and adjust prandial therapy if needed.
Stop or escalate criteria
- Escalate urgently for recurrent or severe hypoglycemia.
- Escalate if fasting targets remain persistently above goal despite appropriate titration and adherence support.
- Escalate immediately when ketosis symptoms or significant clinical deterioration appear.